Veru

+$0.31 (+4.28%) Today

-$0.19 (-2.51%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Veru and other stocks, options, and ETFs commission-free!

About VERU

Veru Inc. Common Stock, also called Veru, is an oncology biopharmaceutical company engaged in developing novel medicines for the management of prostate cancer and breast cancer.

CEO

Mitchell Shuster Steiner

Employees

339

Headquarters

Miami, Florida

Founded

1996

VERU Key Statistics

Market Cap

612.04M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

4.09M

High Today

$7.72

Low Today

$7.28

Open Price

$7.32

Volume

943.93K

52 Week High

$24.57

52 Week Low

$2.30

VERU News

BenzingaMay 12

Veru: Q2 Earnings Insights

Shares of Veru (NASDAQ:VERU) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share fell 300.00% over the past year t

VERU Earnings

-$0.06

-$0.03

$0.00

$0.03

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

-$0.04 per share

Actual

-$0.04 per share

Replay Earnings Call